Raxwal Tejas, Akel Zeid, Naidu Jotsna, Sundaresh Koravangala
Preventive Medicine, Access Health Care Physicians, Zephyrhills, USA.
Medical School, Florida State University, Tallahassee, USA.
Cureus. 2022 Aug 29;14(8):e28523. doi: 10.7759/cureus.28523. eCollection 2022 Aug.
Multiple neuro-ophthalmological symptoms, such as visual field defects, optic neuritis, and eye movement abnormalities, have been reported with coronavirus disease 2019 (COVID-19) infection. It is unknown whether the COVID-19 vaccine can result in similar neuro-ophthalmological symptoms post-vaccination. Here, we describe a case of optic neuritis after the administration of the mRNA COVID-19 Moderna vaccine. A 47-year-old female presented eight days after receiving the first dose of the Moderna COVID-19 vaccine with impaired vision in the left eye and symptoms consistent with optic neuritis. The patient underwent a workup for infectious etiology, autoimmune diseases, and allergies, which was negative. The patient was treated with a high dose of steroids resulting in the complete resolution of her symptoms. The patient was recommended against the second dose of the mRNA COVID-19 vaccine. Early detection and treatment of optic neuritis are important to prevent the long-term sequelae of neuritis with impaired vision.
多项神经眼科症状,如视野缺损、视神经炎和眼球运动异常,已在2019冠状病毒病(COVID-19)感染中被报道。目前尚不清楚COVID-19疫苗接种后是否会导致类似的神经眼科症状。在此,我们描述一例接种mRNA COVID-19莫德纳疫苗后发生视神经炎的病例。一名47岁女性在接种第一剂莫德纳COVID-19疫苗八天后出现左眼视力受损及与视神经炎相符的症状。该患者接受了针对感染性病因、自身免疫性疾病和过敏的检查,结果均为阴性。患者接受了高剂量类固醇治疗,症状完全缓解。建议该患者不要接种第二剂mRNA COVID-19疫苗。对视神经炎进行早期检测和治疗对于预防视力受损的神经炎长期后遗症很重要。